GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Kindstar Globalgene Technology Inc (HKSE:09960) » Definitions » Net Issuance of Debt

Kindstar Globalgene Technology (HKSE:09960) Net Issuance of Debt : HK$-30 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Kindstar Globalgene Technology Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. Kindstar Globalgene Technology's net issuance of debt for the six months ended in Dec. 2023 was HK$-46 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-30 Mil.

Kindstar Globalgene Technology Net Issuance of Debt Historical Data

The historical data trend for Kindstar Globalgene Technology's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kindstar Globalgene Technology Net Issuance of Debt Chart

Kindstar Globalgene Technology Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Issuance of Debt
Get a 7-Day Free Trial - 47.42 -48.98 201.01 -29.64

Kindstar Globalgene Technology Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 201.01 16.30 -45.94

Kindstar Globalgene Technology Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kindstar Globalgene Technology Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Kindstar Globalgene Technology's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Kindstar Globalgene Technology (HKSE:09960) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Kindstar Globalgene Technology Inc (HKSE:09960) » Definitions » Net Issuance of Debt
Comparable Companies
HKSE:06667 HKSE:08037 HKSE:02427 HKSE:08225 HKSE:08247 HKSE:00928 HKSE:02325 TMO DHR SHSE:603259 IQV IDXX A XSWX:LONN MTD ICLR LH ILMN DGX WAT
Traded in Other Exchanges
N/A
Address
Biolake D2-1, 666 Gaoxin Road, East Lake High Tech Zone, Hubei Province, Wuhan, CHN
Website
https://www.kindstar.com.cn
Kindstar Globalgene Technology Inc is principally engaged in the provision of clinical testing services. It organizes the business into nine segments, including hematology testing, genetic disease and rare disease testing, infectious disease testing, oncology testing, neurology testing, maternity-related testing, COVID-19-related testing, routine testing, and Other segment provides Testing services for R&D projects and others and miscellaneous services.

Kindstar Globalgene Technology (HKSE:09960) Headlines

No Headlines